Anyone have one? I am presently writing one for our practice as we
seem to be doing an inordinate number of lipids with all the
subsequent workload. The Darlington PCT Guidelines seem reasonable,
although I do not think we will go above 40mgs with Simvastatin. We
are then likely to switch the non-responders to Atorva. I notice that
these guidelines suggest a switch from Simva 40 to Atorva 40. Do
others think there is any merit in starting at 10mgs? From past
experience I have found Atorva 10 to be very effective. Additionally
what is the rationale for switching those with side effects to
Pravastatin?
Unable to tolerate a statin - is it then reasonable to just go with Ezetrol??
We have a large number of patients labelled as 'hyperlipidaemia' - I
want to make things as simple as possible. And am thinking of 5
groups:-
Secondary prevention for IHD, PVD & Cerebrovascular Disease
Diabetics
Primary prevention for CVD risk >
Those with CVD risk 17-20 - Re-code as 'Raised lipids' - Re-test at 3 years
Those with CVD risk <17 - Re-code as 'Raised lipids' - re-test no
sooner than 5 years.
Any thoughts, and for simplicity should we lump all diabetics together
or just follow the age related guidelines? Thoughts please??
--
Best Wishes
Paul Bromley
www.informatiks.com
Custom EMIS LV Software.
vuE | GPLabels | GPDocs | eGFRChecker
|